nodes	percent_of_prediction	percent_of_DWPC	metapath
Omeprazole—CYP1A1—kidney cancer	0.176	0.653	CbGaD
Omeprazole—ABCB1—kidney cancer	0.0936	0.347	CbGaD
Omeprazole—CYP1B1—Erlotinib—kidney cancer	0.0329	0.0675	CbGbCtD
Omeprazole—CYP1B1—Paclitaxel—kidney cancer	0.0301	0.0618	CbGbCtD
Omeprazole—ABCC3—Vincristine—kidney cancer	0.03	0.0617	CbGbCtD
Omeprazole—ABCG2—Pazopanib—kidney cancer	0.0219	0.045	CbGbCtD
Omeprazole—ABCG2—Dactinomycin—kidney cancer	0.02	0.0411	CbGbCtD
Omeprazole—ABCC3—Doxorubicin—kidney cancer	0.0188	0.0385	CbGbCtD
Omeprazole—CYP1B1—Doxorubicin—kidney cancer	0.0162	0.0333	CbGbCtD
Omeprazole—ABCG2—Erlotinib—kidney cancer	0.0156	0.0321	CbGbCtD
Omeprazole—ABCB1—Temsirolimus—kidney cancer	0.015	0.0309	CbGbCtD
Omeprazole—CYP1A1—Erlotinib—kidney cancer	0.0144	0.0296	CbGbCtD
Omeprazole—ABCG2—Paclitaxel—kidney cancer	0.0143	0.0294	CbGbCtD
Omeprazole—CYP2D6—Temsirolimus—kidney cancer	0.0142	0.0291	CbGbCtD
Omeprazole—CYP3A4—Everolimus—kidney cancer	0.0133	0.0274	CbGbCtD
Omeprazole—ABCG2—Sorafenib—kidney cancer	0.0127	0.0261	CbGbCtD
Omeprazole—ABCG2—Vincristine—kidney cancer	0.0123	0.0253	CbGbCtD
Omeprazole—CYP2C8—Pazopanib—kidney cancer	0.0117	0.024	CbGbCtD
Omeprazole—ABCG2—Sunitinib—kidney cancer	0.0103	0.0211	CbGbCtD
Omeprazole—CYP1A2—Pazopanib—kidney cancer	0.00903	0.0185	CbGbCtD
Omeprazole—CYP3A4—Temsirolimus—kidney cancer	0.00901	0.0185	CbGbCtD
Omeprazole—CYP2C9—Capecitabine—kidney cancer	0.00849	0.0174	CbGbCtD
Omeprazole—CYP2C8—Erlotinib—kidney cancer	0.00833	0.0171	CbGbCtD
Omeprazole—ABCB1—Pazopanib—kidney cancer	0.0079	0.0162	CbGbCtD
Omeprazole—ABCG2—Doxorubicin—kidney cancer	0.00771	0.0158	CbGbCtD
Omeprazole—CYP2C8—Paclitaxel—kidney cancer	0.00762	0.0156	CbGbCtD
Omeprazole—CYP2D6—Pazopanib—kidney cancer	0.00744	0.0153	CbGbCtD
Omeprazole—ABCB1—Dactinomycin—kidney cancer	0.00722	0.0148	CbGbCtD
Omeprazole—CYP2C8—Sorafenib—kidney cancer	0.00677	0.0139	CbGbCtD
Omeprazole—CYP1A2—Erlotinib—kidney cancer	0.00645	0.0132	CbGbCtD
Omeprazole—ABCB1—Gemcitabine—kidney cancer	0.00571	0.0117	CbGbCtD
Omeprazole—CYP2C19—Sorafenib—kidney cancer	0.00568	0.0117	CbGbCtD
Omeprazole—ABCB1—Erlotinib—kidney cancer	0.00564	0.0116	CbGbCtD
Omeprazole—CYP2C9—Paclitaxel—kidney cancer	0.00532	0.0109	CbGbCtD
Omeprazole—CYP2D6—Erlotinib—kidney cancer	0.00531	0.0109	CbGbCtD
Omeprazole—CYP1A2—Sorafenib—kidney cancer	0.00524	0.0108	CbGbCtD
Omeprazole—ABCB1—Paclitaxel—kidney cancer	0.00516	0.0106	CbGbCtD
Omeprazole—CYP3A4—Pazopanib—kidney cancer	0.00473	0.00972	CbGbCtD
Omeprazole—CYP2C9—Sorafenib—kidney cancer	0.00472	0.00969	CbGbCtD
Omeprazole—ABCB1—Sorafenib—kidney cancer	0.00458	0.00941	CbGbCtD
Omeprazole—ABCB1—Vinblastine—kidney cancer	0.00453	0.00929	CbGbCtD
Omeprazole—ABCB1—Vincristine—kidney cancer	0.00445	0.00913	CbGbCtD
Omeprazole—CYP2D6—Sorafenib—kidney cancer	0.00432	0.00887	CbGbCtD
Omeprazole—CYP2D6—Vinblastine—kidney cancer	0.00426	0.00875	CbGbCtD
Omeprazole—ABCB1—Sunitinib—kidney cancer	0.00371	0.00762	CbGbCtD
Omeprazole—CYP3A4—Erlotinib—kidney cancer	0.00338	0.00693	CbGbCtD
Omeprazole—CYP3A4—Paclitaxel—kidney cancer	0.00309	0.00635	CbGbCtD
Omeprazole—ABCB1—Doxorubicin—kidney cancer	0.00278	0.00571	CbGbCtD
Omeprazole—CYP3A4—Sorafenib—kidney cancer	0.00275	0.00564	CbGbCtD
Omeprazole—CYP3A4—Vinblastine—kidney cancer	0.00271	0.00557	CbGbCtD
Omeprazole—CYP3A4—Vincristine—kidney cancer	0.00267	0.00547	CbGbCtD
Omeprazole—CYP2D6—Doxorubicin—kidney cancer	0.00262	0.00538	CbGbCtD
Omeprazole—CYP3A4—Sunitinib—kidney cancer	0.00222	0.00457	CbGbCtD
Omeprazole—CYP2C19—urine—kidney cancer	0.00171	0.099	CbGeAlD
Omeprazole—CYP3A4—Doxorubicin—kidney cancer	0.00167	0.00342	CbGbCtD
Omeprazole—CYP1A2—urine—kidney cancer	0.00139	0.0808	CbGeAlD
Omeprazole—CYP2C9—urine—kidney cancer	0.00132	0.0767	CbGeAlD
Omeprazole—ATP4A—renal system—kidney cancer	0.0012	0.0693	CbGeAlD
Omeprazole—ATP4A—kidney—kidney cancer	0.00116	0.067	CbGeAlD
Omeprazole—CYP3A4—urine—kidney cancer	0.00101	0.0585	CbGeAlD
Omeprazole—CYP2D6—urine—kidney cancer	0.000993	0.0576	CbGeAlD
Omeprazole—CYP11A1—gonad—kidney cancer	0.000703	0.0408	CbGeAlD
Omeprazole—ABCC3—renal system—kidney cancer	0.000608	0.0353	CbGeAlD
Omeprazole—Rabeprazole—CYP1A1—kidney cancer	0.000606	0.374	CrCbGaD
Omeprazole—ABCC3—kidney—kidney cancer	0.000588	0.0341	CbGeAlD
Omeprazole—CYP1B1—nephron tubule—kidney cancer	0.000524	0.0304	CbGeAlD
Omeprazole—CYP1B1—renal system—kidney cancer	0.000476	0.0276	CbGeAlD
Omeprazole—CYP1B1—kidney—kidney cancer	0.00046	0.0267	CbGeAlD
Omeprazole—Lansoprazole—CYP1A1—kidney cancer	0.000452	0.279	CrCbGaD
Omeprazole—CYP1B1—cortex of kidney—kidney cancer	0.000448	0.026	CbGeAlD
Omeprazole—CYP1B1—gonad—kidney cancer	0.000427	0.0248	CbGeAlD
Omeprazole—ABCG2—nephron tubule—kidney cancer	0.00039	0.0226	CbGeAlD
Omeprazole—CYP2C8—renal system—kidney cancer	0.000365	0.0211	CbGeAlD
Omeprazole—CYP2C8—kidney—kidney cancer	0.000352	0.0204	CbGeAlD
Omeprazole—CYP1A2—renal system—kidney cancer	0.000341	0.0198	CbGeAlD
Omeprazole—CYP1A1—renal system—kidney cancer	0.000336	0.0195	CbGeAlD
Omeprazole—CYP1A1—kidney—kidney cancer	0.000325	0.0189	CbGeAlD
Omeprazole—Pantoprazole—ABCB1—kidney cancer	0.000322	0.199	CrCbGaD
Omeprazole—CYP1A1—cardiac atrium—kidney cancer	0.000301	0.0175	CbGeAlD
Omeprazole—CYP3A4—renal system—kidney cancer	0.000247	0.0143	CbGeAlD
Omeprazole—CYP2D6—renal system—kidney cancer	0.000243	0.0141	CbGeAlD
Omeprazole—Lansoprazole—ABCB1—kidney cancer	0.00024	0.148	CrCbGaD
Omeprazole—CYP3A4—kidney—kidney cancer	0.000239	0.0138	CbGeAlD
Omeprazole—CYP2D6—kidney—kidney cancer	0.000235	0.0136	CbGeAlD
Omeprazole—ABCB1—nephron tubule—kidney cancer	0.000192	0.0111	CbGeAlD
Omeprazole—ABCB1—renal system—kidney cancer	0.000175	0.0101	CbGeAlD
Omeprazole—ABCB1—kidney—kidney cancer	0.000169	0.0098	CbGeAlD
Omeprazole—ABCB1—cortex of kidney—kidney cancer	0.000165	0.00954	CbGeAlD
Omeprazole—ABCB1—gonad—kidney cancer	0.000157	0.00909	CbGeAlD
Omeprazole—Nausea—Erlotinib—kidney cancer	5.11e-05	0.000308	CcSEcCtD
Omeprazole—Alopecia—Capecitabine—kidney cancer	5.1e-05	0.000308	CcSEcCtD
Omeprazole—Dry mouth—Paclitaxel—kidney cancer	5.1e-05	0.000308	CcSEcCtD
Omeprazole—Diarrhoea—Sunitinib—kidney cancer	5.09e-05	0.000307	CcSEcCtD
Omeprazole—Mental disorder—Capecitabine—kidney cancer	5.06e-05	0.000305	CcSEcCtD
Omeprazole—Asthenia—Dactinomycin—kidney cancer	5.05e-05	0.000305	CcSEcCtD
Omeprazole—Confusional state—Paclitaxel—kidney cancer	5.04e-05	0.000304	CcSEcCtD
Omeprazole—Blood creatinine increased—Doxorubicin—kidney cancer	5.04e-05	0.000304	CcSEcCtD
Omeprazole—Malnutrition—Capecitabine—kidney cancer	5.03e-05	0.000303	CcSEcCtD
Omeprazole—Anaphylactic shock—Paclitaxel—kidney cancer	5e-05	0.000302	CcSEcCtD
Omeprazole—Abdominal pain—Vincristine—kidney cancer	4.98e-05	0.0003	CcSEcCtD
Omeprazole—Body temperature increased—Vincristine—kidney cancer	4.98e-05	0.0003	CcSEcCtD
Omeprazole—Infection—Paclitaxel—kidney cancer	4.97e-05	0.0003	CcSEcCtD
Omeprazole—Flatulence—Capecitabine—kidney cancer	4.95e-05	0.000299	CcSEcCtD
Omeprazole—Dry skin—Doxorubicin—kidney cancer	4.93e-05	0.000298	CcSEcCtD
Omeprazole—Dysgeusia—Capecitabine—kidney cancer	4.92e-05	0.000297	CcSEcCtD
Omeprazole—Dizziness—Sunitinib—kidney cancer	4.92e-05	0.000297	CcSEcCtD
Omeprazole—Feeling abnormal—Gemcitabine—kidney cancer	4.92e-05	0.000297	CcSEcCtD
Omeprazole—Shock—Paclitaxel—kidney cancer	4.92e-05	0.000297	CcSEcCtD
Omeprazole—Vomiting—Sorafenib—kidney cancer	4.92e-05	0.000297	CcSEcCtD
Omeprazole—Abdominal pain upper—Doxorubicin—kidney cancer	4.91e-05	0.000297	CcSEcCtD
Omeprazole—Nervous system disorder—Paclitaxel—kidney cancer	4.9e-05	0.000296	CcSEcCtD
Omeprazole—Hypokalaemia—Doxorubicin—kidney cancer	4.9e-05	0.000296	CcSEcCtD
Omeprazole—Thrombocytopenia—Paclitaxel—kidney cancer	4.89e-05	0.000296	CcSEcCtD
Omeprazole—Tachycardia—Paclitaxel—kidney cancer	4.88e-05	0.000295	CcSEcCtD
Omeprazole—Rash—Sorafenib—kidney cancer	4.88e-05	0.000294	CcSEcCtD
Omeprazole—Dermatitis—Sorafenib—kidney cancer	4.87e-05	0.000294	CcSEcCtD
Omeprazole—Back pain—Capecitabine—kidney cancer	4.86e-05	0.000294	CcSEcCtD
Omeprazole—Breast disorder—Doxorubicin—kidney cancer	4.86e-05	0.000294	CcSEcCtD
Omeprazole—Skin disorder—Paclitaxel—kidney cancer	4.86e-05	0.000293	CcSEcCtD
Omeprazole—Toxic epidermal necrolysis—Doxorubicin—kidney cancer	4.85e-05	0.000293	CcSEcCtD
Omeprazole—Aspartate aminotransferase increased—Doxorubicin—kidney cancer	4.85e-05	0.000293	CcSEcCtD
Omeprazole—Headache—Sorafenib—kidney cancer	4.84e-05	0.000292	CcSEcCtD
Omeprazole—Muscle spasms—Capecitabine—kidney cancer	4.83e-05	0.000292	CcSEcCtD
Omeprazole—Hyperhidrosis—Paclitaxel—kidney cancer	4.83e-05	0.000292	CcSEcCtD
Omeprazole—Diarrhoea—Dactinomycin—kidney cancer	4.82e-05	0.000291	CcSEcCtD
Omeprazole—Anorexia—Paclitaxel—kidney cancer	4.77e-05	0.000288	CcSEcCtD
Omeprazole—Gastritis—Doxorubicin—kidney cancer	4.76e-05	0.000287	CcSEcCtD
Omeprazole—Muscular weakness—Doxorubicin—kidney cancer	4.75e-05	0.000286	CcSEcCtD
Omeprazole—Alanine aminotransferase increased—Doxorubicin—kidney cancer	4.75e-05	0.000286	CcSEcCtD
Omeprazole—Vision blurred—Capecitabine—kidney cancer	4.74e-05	0.000286	CcSEcCtD
Omeprazole—Vomiting—Sunitinib—kidney cancer	4.73e-05	0.000286	CcSEcCtD
Omeprazole—Body temperature increased—Gemcitabine—kidney cancer	4.72e-05	0.000285	CcSEcCtD
Omeprazole—Tremor—Capecitabine—kidney cancer	4.71e-05	0.000284	CcSEcCtD
Omeprazole—Rash—Sunitinib—kidney cancer	4.69e-05	0.000283	CcSEcCtD
Omeprazole—Dermatitis—Sunitinib—kidney cancer	4.69e-05	0.000283	CcSEcCtD
Omeprazole—Abdominal distension—Doxorubicin—kidney cancer	4.68e-05	0.000283	CcSEcCtD
Omeprazole—Ill-defined disorder—Capecitabine—kidney cancer	4.66e-05	0.000282	CcSEcCtD
Omeprazole—Headache—Sunitinib—kidney cancer	4.66e-05	0.000281	CcSEcCtD
Omeprazole—Asthma—Doxorubicin—kidney cancer	4.65e-05	0.000281	CcSEcCtD
Omeprazole—Influenza—Doxorubicin—kidney cancer	4.65e-05	0.000281	CcSEcCtD
Omeprazole—Dysphagia—Doxorubicin—kidney cancer	4.65e-05	0.000281	CcSEcCtD
Omeprazole—Anaemia—Capecitabine—kidney cancer	4.65e-05	0.00028	CcSEcCtD
Omeprazole—Hypersensitivity—Vincristine—kidney cancer	4.64e-05	0.00028	CcSEcCtD
Omeprazole—Nausea—Sorafenib—kidney cancer	4.59e-05	0.000277	CcSEcCtD
Omeprazole—Pancreatitis—Doxorubicin—kidney cancer	4.56e-05	0.000275	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Paclitaxel—kidney cancer	4.55e-05	0.000275	CcSEcCtD
Omeprazole—Malaise—Capecitabine—kidney cancer	4.53e-05	0.000274	CcSEcCtD
Omeprazole—Angina pectoris—Doxorubicin—kidney cancer	4.53e-05	0.000273	CcSEcCtD
Omeprazole—Insomnia—Paclitaxel—kidney cancer	4.52e-05	0.000273	CcSEcCtD
Omeprazole—Vertigo—Capecitabine—kidney cancer	4.52e-05	0.000273	CcSEcCtD
Omeprazole—Asthenia—Vincristine—kidney cancer	4.52e-05	0.000273	CcSEcCtD
Omeprazole—Leukopenia—Capecitabine—kidney cancer	4.5e-05	0.000272	CcSEcCtD
Omeprazole—Paraesthesia—Paclitaxel—kidney cancer	4.49e-05	0.000271	CcSEcCtD
Omeprazole—Vomiting—Dactinomycin—kidney cancer	4.48e-05	0.00027	CcSEcCtD
Omeprazole—Dyspnoea—Paclitaxel—kidney cancer	4.46e-05	0.000269	CcSEcCtD
Omeprazole—Somnolence—Paclitaxel—kidney cancer	4.44e-05	0.000268	CcSEcCtD
Omeprazole—Palpitations—Capecitabine—kidney cancer	4.44e-05	0.000268	CcSEcCtD
Omeprazole—Rash—Dactinomycin—kidney cancer	4.44e-05	0.000268	CcSEcCtD
Omeprazole—Nausea—Sunitinib—kidney cancer	4.42e-05	0.000267	CcSEcCtD
Omeprazole—Pancytopenia—Doxorubicin—kidney cancer	4.42e-05	0.000267	CcSEcCtD
Omeprazole—Dyspepsia—Paclitaxel—kidney cancer	4.4e-05	0.000266	CcSEcCtD
Omeprazole—Cough—Capecitabine—kidney cancer	4.39e-05	0.000265	CcSEcCtD
Omeprazole—Dysuria—Doxorubicin—kidney cancer	4.35e-05	0.000263	CcSEcCtD
Omeprazole—Neutropenia—Doxorubicin—kidney cancer	4.35e-05	0.000263	CcSEcCtD
Omeprazole—Decreased appetite—Paclitaxel—kidney cancer	4.35e-05	0.000262	CcSEcCtD
Omeprazole—Hypertension—Capecitabine—kidney cancer	4.34e-05	0.000262	CcSEcCtD
Omeprazole—Upper respiratory tract infection—Doxorubicin—kidney cancer	4.32e-05	0.000261	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Paclitaxel—kidney cancer	4.32e-05	0.000261	CcSEcCtD
Omeprazole—Fatigue—Paclitaxel—kidney cancer	4.31e-05	0.00026	CcSEcCtD
Omeprazole—Diarrhoea—Vincristine—kidney cancer	4.31e-05	0.00026	CcSEcCtD
Omeprazole—Pollakiuria—Doxorubicin—kidney cancer	4.3e-05	0.000259	CcSEcCtD
Omeprazole—Asthenia—Gemcitabine—kidney cancer	4.28e-05	0.000259	CcSEcCtD
Omeprazole—Chest pain—Capecitabine—kidney cancer	4.28e-05	0.000258	CcSEcCtD
Omeprazole—Arthralgia—Capecitabine—kidney cancer	4.28e-05	0.000258	CcSEcCtD
Omeprazole—Myalgia—Capecitabine—kidney cancer	4.28e-05	0.000258	CcSEcCtD
Omeprazole—Pain—Paclitaxel—kidney cancer	4.27e-05	0.000258	CcSEcCtD
Omeprazole—Constipation—Paclitaxel—kidney cancer	4.27e-05	0.000258	CcSEcCtD
Omeprazole—Anxiety—Capecitabine—kidney cancer	4.26e-05	0.000257	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Capecitabine—kidney cancer	4.25e-05	0.000257	CcSEcCtD
Omeprazole—Photosensitivity reaction—Doxorubicin—kidney cancer	4.24e-05	0.000256	CcSEcCtD
Omeprazole—Weight increased—Doxorubicin—kidney cancer	4.23e-05	0.000256	CcSEcCtD
Omeprazole—Discomfort—Capecitabine—kidney cancer	4.23e-05	0.000255	CcSEcCtD
Omeprazole—Pruritus—Gemcitabine—kidney cancer	4.22e-05	0.000255	CcSEcCtD
Omeprazole—Weight decreased—Doxorubicin—kidney cancer	4.21e-05	0.000254	CcSEcCtD
Omeprazole—Dry mouth—Capecitabine—kidney cancer	4.19e-05	0.000253	CcSEcCtD
Omeprazole—Nausea—Dactinomycin—kidney cancer	4.18e-05	0.000253	CcSEcCtD
Omeprazole—Dizziness—Vincristine—kidney cancer	4.16e-05	0.000251	CcSEcCtD
Omeprazole—Infestation NOS—Doxorubicin—kidney cancer	4.15e-05	0.00025	CcSEcCtD
Omeprazole—Infestation—Doxorubicin—kidney cancer	4.15e-05	0.00025	CcSEcCtD
Omeprazole—Confusional state—Capecitabine—kidney cancer	4.14e-05	0.00025	CcSEcCtD
Omeprazole—Feeling abnormal—Paclitaxel—kidney cancer	4.12e-05	0.000249	CcSEcCtD
Omeprazole—Stevens-Johnson syndrome—Doxorubicin—kidney cancer	4.11e-05	0.000248	CcSEcCtD
Omeprazole—Gastrointestinal pain—Paclitaxel—kidney cancer	4.09e-05	0.000247	CcSEcCtD
Omeprazole—Diarrhoea—Gemcitabine—kidney cancer	4.09e-05	0.000247	CcSEcCtD
Omeprazole—Renal failure—Doxorubicin—kidney cancer	4.08e-05	0.000246	CcSEcCtD
Omeprazole—Infection—Capecitabine—kidney cancer	4.08e-05	0.000246	CcSEcCtD
Omeprazole—Stomatitis—Doxorubicin—kidney cancer	4.04e-05	0.000244	CcSEcCtD
Omeprazole—Jaundice—Doxorubicin—kidney cancer	4.04e-05	0.000244	CcSEcCtD
Omeprazole—Shock—Capecitabine—kidney cancer	4.04e-05	0.000244	CcSEcCtD
Omeprazole—Urinary tract infection—Doxorubicin—kidney cancer	4.03e-05	0.000243	CcSEcCtD
Omeprazole—Conjunctivitis—Doxorubicin—kidney cancer	4.03e-05	0.000243	CcSEcCtD
Omeprazole—Nervous system disorder—Capecitabine—kidney cancer	4.02e-05	0.000243	CcSEcCtD
Omeprazole—Thrombocytopenia—Capecitabine—kidney cancer	4.02e-05	0.000243	CcSEcCtD
Omeprazole—Tachycardia—Capecitabine—kidney cancer	4e-05	0.000242	CcSEcCtD
Omeprazole—Vomiting—Vincristine—kidney cancer	4e-05	0.000242	CcSEcCtD
Omeprazole—Skin disorder—Capecitabine—kidney cancer	3.98e-05	0.000241	CcSEcCtD
Omeprazole—Urticaria—Paclitaxel—kidney cancer	3.97e-05	0.00024	CcSEcCtD
Omeprazole—Rash—Vincristine—kidney cancer	3.97e-05	0.00024	CcSEcCtD
Omeprazole—Hyperhidrosis—Capecitabine—kidney cancer	3.97e-05	0.000239	CcSEcCtD
Omeprazole—Dermatitis—Vincristine—kidney cancer	3.96e-05	0.000239	CcSEcCtD
Omeprazole—Haematuria—Doxorubicin—kidney cancer	3.95e-05	0.000239	CcSEcCtD
Omeprazole—Abdominal pain—Paclitaxel—kidney cancer	3.95e-05	0.000239	CcSEcCtD
Omeprazole—Body temperature increased—Paclitaxel—kidney cancer	3.95e-05	0.000239	CcSEcCtD
Omeprazole—Headache—Vincristine—kidney cancer	3.94e-05	0.000238	CcSEcCtD
Omeprazole—Hepatobiliary disease—Doxorubicin—kidney cancer	3.92e-05	0.000237	CcSEcCtD
Omeprazole—Epistaxis—Doxorubicin—kidney cancer	3.91e-05	0.000236	CcSEcCtD
Omeprazole—Anorexia—Capecitabine—kidney cancer	3.91e-05	0.000236	CcSEcCtD
Omeprazole—Sinusitis—Doxorubicin—kidney cancer	3.89e-05	0.000235	CcSEcCtD
Omeprazole—Agranulocytosis—Doxorubicin—kidney cancer	3.87e-05	0.000234	CcSEcCtD
Omeprazole—Vomiting—Gemcitabine—kidney cancer	3.8e-05	0.000229	CcSEcCtD
Omeprazole—Bradycardia—Doxorubicin—kidney cancer	3.79e-05	0.000229	CcSEcCtD
Omeprazole—Rash—Gemcitabine—kidney cancer	3.76e-05	0.000227	CcSEcCtD
Omeprazole—Dermatitis—Gemcitabine—kidney cancer	3.76e-05	0.000227	CcSEcCtD
Omeprazole—Headache—Gemcitabine—kidney cancer	3.74e-05	0.000226	CcSEcCtD
Omeprazole—Nausea—Vincristine—kidney cancer	3.74e-05	0.000226	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Capecitabine—kidney cancer	3.74e-05	0.000226	CcSEcCtD
Omeprazole—Rhinitis—Doxorubicin—kidney cancer	3.73e-05	0.000225	CcSEcCtD
Omeprazole—Hepatitis—Doxorubicin—kidney cancer	3.72e-05	0.000225	CcSEcCtD
Omeprazole—Insomnia—Capecitabine—kidney cancer	3.71e-05	0.000224	CcSEcCtD
Omeprazole—Hypoaesthesia—Doxorubicin—kidney cancer	3.7e-05	0.000224	CcSEcCtD
Omeprazole—Pharyngitis—Doxorubicin—kidney cancer	3.69e-05	0.000223	CcSEcCtD
Omeprazole—Paraesthesia—Capecitabine—kidney cancer	3.68e-05	0.000222	CcSEcCtD
Omeprazole—Hypersensitivity—Paclitaxel—kidney cancer	3.68e-05	0.000222	CcSEcCtD
Omeprazole—Urinary tract disorder—Doxorubicin—kidney cancer	3.68e-05	0.000222	CcSEcCtD
Omeprazole—Oedema peripheral—Doxorubicin—kidney cancer	3.67e-05	0.000221	CcSEcCtD
Omeprazole—Connective tissue disorder—Doxorubicin—kidney cancer	3.66e-05	0.000221	CcSEcCtD
Omeprazole—Dyspnoea—Capecitabine—kidney cancer	3.66e-05	0.000221	CcSEcCtD
Omeprazole—Urethral disorder—Doxorubicin—kidney cancer	3.65e-05	0.00022	CcSEcCtD
Omeprazole—Dyspepsia—Capecitabine—kidney cancer	3.61e-05	0.000218	CcSEcCtD
Omeprazole—Visual impairment—Doxorubicin—kidney cancer	3.59e-05	0.000217	CcSEcCtD
Omeprazole—Asthenia—Paclitaxel—kidney cancer	3.59e-05	0.000217	CcSEcCtD
Omeprazole—Decreased appetite—Capecitabine—kidney cancer	3.57e-05	0.000215	CcSEcCtD
Omeprazole—Nausea—Gemcitabine—kidney cancer	3.55e-05	0.000214	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Capecitabine—kidney cancer	3.54e-05	0.000214	CcSEcCtD
Omeprazole—Fatigue—Capecitabine—kidney cancer	3.54e-05	0.000214	CcSEcCtD
Omeprazole—Pruritus—Paclitaxel—kidney cancer	3.54e-05	0.000214	CcSEcCtD
Omeprazole—Erythema multiforme—Doxorubicin—kidney cancer	3.52e-05	0.000212	CcSEcCtD
Omeprazole—Constipation—Capecitabine—kidney cancer	3.51e-05	0.000212	CcSEcCtD
Omeprazole—Pain—Capecitabine—kidney cancer	3.51e-05	0.000212	CcSEcCtD
Omeprazole—Eye disorder—Doxorubicin—kidney cancer	3.48e-05	0.00021	CcSEcCtD
Omeprazole—Tinnitus—Doxorubicin—kidney cancer	3.47e-05	0.00021	CcSEcCtD
Omeprazole—Flushing—Doxorubicin—kidney cancer	3.45e-05	0.000209	CcSEcCtD
Omeprazole—Diarrhoea—Paclitaxel—kidney cancer	3.42e-05	0.000207	CcSEcCtD
Omeprazole—Feeling abnormal—Capecitabine—kidney cancer	3.38e-05	0.000204	CcSEcCtD
Omeprazole—Immune system disorder—Doxorubicin—kidney cancer	3.36e-05	0.000203	CcSEcCtD
Omeprazole—Gastrointestinal pain—Capecitabine—kidney cancer	3.35e-05	0.000203	CcSEcCtD
Omeprazole—Mediastinal disorder—Doxorubicin—kidney cancer	3.35e-05	0.000203	CcSEcCtD
Omeprazole—Chills—Doxorubicin—kidney cancer	3.34e-05	0.000202	CcSEcCtD
Omeprazole—Dizziness—Paclitaxel—kidney cancer	3.31e-05	0.0002	CcSEcCtD
Omeprazole—Alopecia—Doxorubicin—kidney cancer	3.29e-05	0.000199	CcSEcCtD
Omeprazole—Mental disorder—Doxorubicin—kidney cancer	3.26e-05	0.000197	CcSEcCtD
Omeprazole—Urticaria—Capecitabine—kidney cancer	3.26e-05	0.000197	CcSEcCtD
Omeprazole—Abdominal pain—Capecitabine—kidney cancer	3.24e-05	0.000196	CcSEcCtD
Omeprazole—Body temperature increased—Capecitabine—kidney cancer	3.24e-05	0.000196	CcSEcCtD
Omeprazole—Malnutrition—Doxorubicin—kidney cancer	3.24e-05	0.000196	CcSEcCtD
Omeprazole—Flatulence—Doxorubicin—kidney cancer	3.19e-05	0.000193	CcSEcCtD
Omeprazole—Tension—Doxorubicin—kidney cancer	3.18e-05	0.000192	CcSEcCtD
Omeprazole—Vomiting—Paclitaxel—kidney cancer	3.18e-05	0.000192	CcSEcCtD
Omeprazole—Dysgeusia—Doxorubicin—kidney cancer	3.17e-05	0.000192	CcSEcCtD
Omeprazole—Rash—Paclitaxel—kidney cancer	3.15e-05	0.00019	CcSEcCtD
Omeprazole—Dermatitis—Paclitaxel—kidney cancer	3.15e-05	0.00019	CcSEcCtD
Omeprazole—Nervousness—Doxorubicin—kidney cancer	3.15e-05	0.00019	CcSEcCtD
Omeprazole—Back pain—Doxorubicin—kidney cancer	3.13e-05	0.000189	CcSEcCtD
Omeprazole—Headache—Paclitaxel—kidney cancer	3.13e-05	0.000189	CcSEcCtD
Omeprazole—Muscle spasms—Doxorubicin—kidney cancer	3.12e-05	0.000188	CcSEcCtD
Omeprazole—Vision blurred—Doxorubicin—kidney cancer	3.05e-05	0.000184	CcSEcCtD
Omeprazole—Hypersensitivity—Capecitabine—kidney cancer	3.02e-05	0.000182	CcSEcCtD
Omeprazole—Ill-defined disorder—Doxorubicin—kidney cancer	3.01e-05	0.000182	CcSEcCtD
Omeprazole—Anaemia—Doxorubicin—kidney cancer	2.99e-05	0.000181	CcSEcCtD
Omeprazole—Agitation—Doxorubicin—kidney cancer	2.98e-05	0.00018	CcSEcCtD
Omeprazole—Nausea—Paclitaxel—kidney cancer	2.97e-05	0.000179	CcSEcCtD
Omeprazole—Asthenia—Capecitabine—kidney cancer	2.94e-05	0.000178	CcSEcCtD
Omeprazole—Malaise—Doxorubicin—kidney cancer	2.92e-05	0.000176	CcSEcCtD
Omeprazole—Vertigo—Doxorubicin—kidney cancer	2.91e-05	0.000176	CcSEcCtD
Omeprazole—Pruritus—Capecitabine—kidney cancer	2.9e-05	0.000175	CcSEcCtD
Omeprazole—Leukopenia—Doxorubicin—kidney cancer	2.9e-05	0.000175	CcSEcCtD
Omeprazole—Palpitations—Doxorubicin—kidney cancer	2.86e-05	0.000173	CcSEcCtD
Omeprazole—Cough—Doxorubicin—kidney cancer	2.83e-05	0.000171	CcSEcCtD
Omeprazole—Diarrhoea—Capecitabine—kidney cancer	2.81e-05	0.000169	CcSEcCtD
Omeprazole—Hypertension—Doxorubicin—kidney cancer	2.8e-05	0.000169	CcSEcCtD
Omeprazole—Arthralgia—Doxorubicin—kidney cancer	2.76e-05	0.000167	CcSEcCtD
Omeprazole—Myalgia—Doxorubicin—kidney cancer	2.76e-05	0.000167	CcSEcCtD
Omeprazole—Chest pain—Doxorubicin—kidney cancer	2.76e-05	0.000167	CcSEcCtD
Omeprazole—Anxiety—Doxorubicin—kidney cancer	2.75e-05	0.000166	CcSEcCtD
Omeprazole—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—kidney cancer	2.74e-05	0.000165	CcSEcCtD
Omeprazole—Discomfort—Doxorubicin—kidney cancer	2.73e-05	0.000165	CcSEcCtD
Omeprazole—Dizziness—Capecitabine—kidney cancer	2.71e-05	0.000164	CcSEcCtD
Omeprazole—Dry mouth—Doxorubicin—kidney cancer	2.7e-05	0.000163	CcSEcCtD
Omeprazole—Confusional state—Doxorubicin—kidney cancer	2.67e-05	0.000161	CcSEcCtD
Omeprazole—Anaphylactic shock—Doxorubicin—kidney cancer	2.64e-05	0.00016	CcSEcCtD
Omeprazole—Infection—Doxorubicin—kidney cancer	2.63e-05	0.000159	CcSEcCtD
Omeprazole—Vomiting—Capecitabine—kidney cancer	2.61e-05	0.000157	CcSEcCtD
Omeprazole—Shock—Doxorubicin—kidney cancer	2.6e-05	0.000157	CcSEcCtD
Omeprazole—Nervous system disorder—Doxorubicin—kidney cancer	2.59e-05	0.000157	CcSEcCtD
Omeprazole—Thrombocytopenia—Doxorubicin—kidney cancer	2.59e-05	0.000156	CcSEcCtD
Omeprazole—Rash—Capecitabine—kidney cancer	2.59e-05	0.000156	CcSEcCtD
Omeprazole—Dermatitis—Capecitabine—kidney cancer	2.58e-05	0.000156	CcSEcCtD
Omeprazole—Tachycardia—Doxorubicin—kidney cancer	2.58e-05	0.000156	CcSEcCtD
Omeprazole—Headache—Capecitabine—kidney cancer	2.57e-05	0.000155	CcSEcCtD
Omeprazole—Skin disorder—Doxorubicin—kidney cancer	2.57e-05	0.000155	CcSEcCtD
Omeprazole—Hyperhidrosis—Doxorubicin—kidney cancer	2.56e-05	0.000154	CcSEcCtD
Omeprazole—Anorexia—Doxorubicin—kidney cancer	2.52e-05	0.000152	CcSEcCtD
Omeprazole—Nausea—Capecitabine—kidney cancer	2.44e-05	0.000147	CcSEcCtD
Omeprazole—Musculoskeletal discomfort—Doxorubicin—kidney cancer	2.41e-05	0.000145	CcSEcCtD
Omeprazole—Insomnia—Doxorubicin—kidney cancer	2.39e-05	0.000144	CcSEcCtD
Omeprazole—Paraesthesia—Doxorubicin—kidney cancer	2.37e-05	0.000143	CcSEcCtD
Omeprazole—Dyspnoea—Doxorubicin—kidney cancer	2.36e-05	0.000142	CcSEcCtD
Omeprazole—Somnolence—Doxorubicin—kidney cancer	2.35e-05	0.000142	CcSEcCtD
Omeprazole—Dyspepsia—Doxorubicin—kidney cancer	2.33e-05	0.000141	CcSEcCtD
Omeprazole—Decreased appetite—Doxorubicin—kidney cancer	2.3e-05	0.000139	CcSEcCtD
Omeprazole—Gastrointestinal disorder—Doxorubicin—kidney cancer	2.28e-05	0.000138	CcSEcCtD
Omeprazole—Fatigue—Doxorubicin—kidney cancer	2.28e-05	0.000138	CcSEcCtD
Omeprazole—Pain—Doxorubicin—kidney cancer	2.26e-05	0.000137	CcSEcCtD
Omeprazole—Constipation—Doxorubicin—kidney cancer	2.26e-05	0.000137	CcSEcCtD
Omeprazole—Feeling abnormal—Doxorubicin—kidney cancer	2.18e-05	0.000132	CcSEcCtD
Omeprazole—Gastrointestinal pain—Doxorubicin—kidney cancer	2.16e-05	0.000131	CcSEcCtD
Omeprazole—Urticaria—Doxorubicin—kidney cancer	2.1e-05	0.000127	CcSEcCtD
Omeprazole—Body temperature increased—Doxorubicin—kidney cancer	2.09e-05	0.000126	CcSEcCtD
Omeprazole—Abdominal pain—Doxorubicin—kidney cancer	2.09e-05	0.000126	CcSEcCtD
Omeprazole—Hypersensitivity—Doxorubicin—kidney cancer	1.95e-05	0.000118	CcSEcCtD
Omeprazole—Asthenia—Doxorubicin—kidney cancer	1.9e-05	0.000115	CcSEcCtD
Omeprazole—Pruritus—Doxorubicin—kidney cancer	1.87e-05	0.000113	CcSEcCtD
Omeprazole—Diarrhoea—Doxorubicin—kidney cancer	1.81e-05	0.000109	CcSEcCtD
Omeprazole—Dizziness—Doxorubicin—kidney cancer	1.75e-05	0.000106	CcSEcCtD
Omeprazole—Vomiting—Doxorubicin—kidney cancer	1.68e-05	0.000102	CcSEcCtD
Omeprazole—Rash—Doxorubicin—kidney cancer	1.67e-05	0.000101	CcSEcCtD
Omeprazole—Dermatitis—Doxorubicin—kidney cancer	1.67e-05	0.000101	CcSEcCtD
Omeprazole—Headache—Doxorubicin—kidney cancer	1.66e-05	0.0001	CcSEcCtD
Omeprazole—Nausea—Doxorubicin—kidney cancer	1.57e-05	9.48e-05	CcSEcCtD
Omeprazole—ABCG2—Metabolism—BCHE—kidney cancer	8.96e-06	0.000152	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ALDH1A1—kidney cancer	8.92e-06	0.000152	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—LDHB—kidney cancer	8.9e-06	0.000151	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—FH—kidney cancer	8.88e-06	0.000151	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—APRT—kidney cancer	8.88e-06	0.000151	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CA9—kidney cancer	8.85e-06	0.000151	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—SLC5A5—kidney cancer	8.85e-06	0.000151	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ALDH1A1—kidney cancer	8.84e-06	0.00015	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	8.79e-06	0.00015	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—BCHE—kidney cancer	8.68e-06	0.000148	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	8.65e-06	0.000147	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SLC5A3—kidney cancer	8.55e-06	0.000146	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PGK1—kidney cancer	8.55e-06	0.000146	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—SLC2A1—kidney cancer	8.55e-06	0.000145	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CCBL1—kidney cancer	8.51e-06	0.000145	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PGK1—kidney cancer	8.48e-06	0.000144	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SLC5A3—kidney cancer	8.48e-06	0.000144	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—VEGFA—kidney cancer	8.46e-06	0.000144	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—LDHB—kidney cancer	8.38e-06	0.000143	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GPC3—kidney cancer	8.35e-06	0.000142	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—LDHB—kidney cancer	8.31e-06	0.000141	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—CRABP1—kidney cancer	8.21e-06	0.00014	CbGpPWpGaD
Omeprazole—ABCG2—Transmembrane transport of small molecules—RAF1—kidney cancer	8.15e-06	0.000139	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CA2—kidney cancer	8.13e-06	0.000138	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK3—kidney cancer	8e-06	0.000136	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—POMC—kidney cancer	7.98e-06	0.000136	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	7.95e-06	0.000135	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ALAD—kidney cancer	7.92e-06	0.000135	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CA9—kidney cancer	7.9e-06	0.000135	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—GSTP1—kidney cancer	7.84e-06	0.000133	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—kidney cancer	7.78e-06	0.000132	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ST3GAL2—kidney cancer	7.73e-06	0.000132	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.72e-06	0.000131	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CA9—kidney cancer	7.71e-06	0.000131	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ITPR2—kidney cancer	7.63e-06	0.00013	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—MAPK1—kidney cancer	7.61e-06	0.00013	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ALDH1A1—kidney cancer	7.55e-06	0.000129	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CRABP1—kidney cancer	7.53e-06	0.000128	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—ABCB1—kidney cancer	7.42e-06	0.000126	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	7.4e-06	0.000126	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PPAT—kidney cancer	7.38e-06	0.000126	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GLIPR1—kidney cancer	7.38e-06	0.000126	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CA9—kidney cancer	7.27e-06	0.000124	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PGK1—kidney cancer	7.24e-06	0.000123	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SLC5A3—kidney cancer	7.24e-06	0.000123	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CA9—kidney cancer	7.21e-06	0.000123	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—GSTM1—kidney cancer	7.2e-06	0.000123	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—kidney cancer	7.19e-06	0.000122	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—GSTP1—kidney cancer	7.13e-06	0.000121	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—LDHB—kidney cancer	7.1e-06	0.000121	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	7.04e-06	0.00012	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—POMC—kidney cancer	7.04e-06	0.00012	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ITPR2—kidney cancer	7e-06	0.000119	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ACHE—kidney cancer	6.96e-06	0.000118	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GSTT1—kidney cancer	6.96e-06	0.000118	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—POMC—kidney cancer	6.9e-06	0.000117	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—APRT—kidney cancer	6.86e-06	0.000117	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—FH—kidney cancer	6.86e-06	0.000117	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—CYP1A1—kidney cancer	6.83e-06	0.000116	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—ABCB1—kidney cancer	6.75e-06	0.000115	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CRABP1—kidney cancer	6.72e-06	0.000114	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—POMC—kidney cancer	6.72e-06	0.000114	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—PIK3CA—kidney cancer	6.61e-06	0.000112	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—SCARB1—kidney cancer	6.59e-06	0.000112	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CRABP1—kidney cancer	6.56e-06	0.000112	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—GSTM1—kidney cancer	6.55e-06	0.000111	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTGS1—kidney cancer	6.52e-06	0.000111	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—POMC—kidney cancer	6.45e-06	0.00011	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GPC3—kidney cancer	6.45e-06	0.00011	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PSMD7—kidney cancer	6.4e-06	0.000109	CbGpPWpGaD
Omeprazole—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—kidney cancer	6.39e-06	0.000109	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ACHE—kidney cancer	6.38e-06	0.000109	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GSTT1—kidney cancer	6.38e-06	0.000109	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PTGS2—kidney cancer	6.36e-06	0.000108	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CA2—kidney cancer	6.27e-06	0.000107	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ITPR2—kidney cancer	6.25e-06	0.000106	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—CYP1A1—kidney cancer	6.21e-06	0.000106	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CRABP1—kidney cancer	6.18e-06	0.000105	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CA9—kidney cancer	6.16e-06	0.000105	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CRABP1—kidney cancer	6.13e-06	0.000104	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALAD—kidney cancer	6.11e-06	0.000104	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ITPR2—kidney cancer	6.1e-06	0.000104	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—BCHE—kidney cancer	6.07e-06	0.000103	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—SCARB1—kidney cancer	6.04e-06	0.000103	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—CYP1A1—kidney cancer	6.02e-06	0.000102	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—SLC5A5—kidney cancer	5.99e-06	0.000102	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTGS1—kidney cancer	5.98e-06	0.000102	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ST3GAL2—kidney cancer	5.97e-06	0.000102	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PSMD7—kidney cancer	5.87e-06	9.98e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ALDH1A1—kidney cancer	5.83e-06	9.92e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—SLC2A1—kidney cancer	5.79e-06	9.85e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.76e-06	9.8e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ITPR2—kidney cancer	5.75e-06	9.78e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTT1—kidney cancer	5.7e-06	9.7e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ACHE—kidney cancer	5.7e-06	9.7e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ITPR2—kidney cancer	5.7e-06	9.7e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.61e-06	9.55e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	5.61e-06	9.54e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PGK1—kidney cancer	5.59e-06	9.51e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SLC5A3—kidney cancer	5.59e-06	9.51e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTT1—kidney cancer	5.56e-06	9.46e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—ACHE—kidney cancer	5.56e-06	9.46e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—BCHE—kidney cancer	5.56e-06	9.46e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PTEN—kidney cancer	5.55e-06	9.45e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PTGS2—kidney cancer	5.51e-06	9.37e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—SLC5A5—kidney cancer	5.49e-06	9.35e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—LDHB—kidney cancer	5.48e-06	9.33e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—SCARB1—kidney cancer	5.39e-06	9.18e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTGS2—kidney cancer	5.36e-06	9.12e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTGS1—kidney cancer	5.34e-06	9.09e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—SLC2A1—kidney cancer	5.3e-06	9.03e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—SCARB1—kidney cancer	5.26e-06	8.96e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—POMC—kidney cancer	5.25e-06	8.94e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ACHE—kidney cancer	5.24e-06	8.92e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTT1—kidney cancer	5.24e-06	8.92e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CRABP1—kidney cancer	5.24e-06	8.91e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PSMD7—kidney cancer	5.24e-06	8.91e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTGS1—kidney cancer	5.21e-06	8.87e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ACHE—kidney cancer	5.19e-06	8.84e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTT1—kidney cancer	5.19e-06	8.84e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	5.15e-06	8.76e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PSMD7—kidney cancer	5.11e-06	8.7e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—POMC—kidney cancer	5.09e-06	8.66e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—BCHE—kidney cancer	4.96e-06	8.45e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SCARB1—kidney cancer	4.96e-06	8.44e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SCARB1—kidney cancer	4.92e-06	8.37e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTGS1—kidney cancer	4.91e-06	8.36e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—SLC5A5—kidney cancer	4.9e-06	8.34e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.9e-06	8.33e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ITPR2—kidney cancer	4.87e-06	8.28e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTGS1—kidney cancer	4.87e-06	8.28e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—BCHE—kidney cancer	4.84e-06	8.24e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GSTP1—kidney cancer	4.83e-06	8.21e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PSMD7—kidney cancer	4.82e-06	8.2e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PTEN—kidney cancer	4.8e-06	8.17e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—SLC5A5—kidney cancer	4.79e-06	8.14e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PSMD7—kidney cancer	4.77e-06	8.12e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CA9—kidney cancer	4.75e-06	8.09e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—SLC2A1—kidney cancer	4.73e-06	8.06e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PTEN—kidney cancer	4.67e-06	7.95e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—POMC—kidney cancer	4.63e-06	7.88e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—SLC2A1—kidney cancer	4.62e-06	7.87e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.59e-06	7.82e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—ABCB1—kidney cancer	4.57e-06	7.77e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—BCHE—kidney cancer	4.57e-06	7.77e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—BCHE—kidney cancer	4.53e-06	7.7e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SLC5A5—kidney cancer	4.51e-06	7.67e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.49e-06	7.64e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—POMC—kidney cancer	4.49e-06	7.64e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SLC5A5—kidney cancer	4.47e-06	7.61e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTT1—kidney cancer	4.44e-06	7.56e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ACHE—kidney cancer	4.44e-06	7.56e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—GSTM1—kidney cancer	4.43e-06	7.55e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GSTP1—kidney cancer	4.42e-06	7.53e-05	CbGpPWpGaD
Omeprazole—ABCB1—Transmembrane transport of small molecules—RAF1—kidney cancer	4.41e-06	7.5e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—SLC2A1—kidney cancer	4.35e-06	7.41e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—SLC2A1—kidney cancer	4.32e-06	7.35e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SCARB1—kidney cancer	4.2e-06	7.15e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	4.19e-06	7.13e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—ABCB1—kidney cancer	4.19e-06	7.13e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTGS1—kidney cancer	4.16e-06	7.08e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PSMD7—kidney cancer	4.08e-06	6.94e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—GSTM1—kidney cancer	4.07e-06	6.92e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTGS2—kidney cancer	4.06e-06	6.91e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CRABP1—kidney cancer	4.04e-06	6.88e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	4.01e-06	6.82e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTP1—kidney cancer	3.95e-06	6.72e-05	CbGpPWpGaD
Omeprazole—CYP11A1—Metabolism—PIK3CA—kidney cancer	3.92e-06	6.66e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—BCHE—kidney cancer	3.87e-06	6.58e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTP1—kidney cancer	3.85e-06	6.56e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—CYP1A1—kidney cancer	3.85e-06	6.56e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SLC5A5—kidney cancer	3.82e-06	6.5e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ITPR2—kidney cancer	3.76e-06	6.39e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—ABCB1—kidney cancer	3.74e-06	6.36e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTGS2—kidney cancer	3.69e-06	6.29e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—SLC2A1—kidney cancer	3.69e-06	6.28e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.65e-06	6.22e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTP1—kidney cancer	3.63e-06	6.18e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—GSTM1—kidney cancer	3.63e-06	6.18e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTP1—kidney cancer	3.6e-06	6.13e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—kidney cancer	3.58e-06	6.09e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—GSTM1—kidney cancer	3.54e-06	6.03e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PTEN—kidney cancer	3.54e-06	6.03e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.45e-06	5.88e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—CYP1A1—kidney cancer	3.44e-06	5.85e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—ABCB1—kidney cancer	3.44e-06	5.85e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ACHE—kidney cancer	3.43e-06	5.83e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTT1—kidney cancer	3.43e-06	5.83e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—ABCB1—kidney cancer	3.41e-06	5.8e-05	CbGpPWpGaD
Omeprazole—CYP2C18—Metabolism—PIK3CA—kidney cancer	3.39e-06	5.77e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—CYP1A1—kidney cancer	3.36e-06	5.71e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—GSTM1—kidney cancer	3.34e-06	5.68e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—GSTM1—kidney cancer	3.31e-06	5.63e-05	CbGpPWpGaD
Omeprazole—ABCC3—Metabolism—PIK3CA—kidney cancer	3.3e-06	5.61e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SCARB1—kidney cancer	3.24e-06	5.52e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PTEN—kidney cancer	3.22e-06	5.48e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTGS1—kidney cancer	3.21e-06	5.46e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	3.17e-06	5.39e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—CYP1A1—kidney cancer	3.16e-06	5.39e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PSMD7—kidney cancer	3.15e-06	5.36e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—CYP1A1—kidney cancer	3.14e-06	5.34e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—POMC—kidney cancer	3.13e-06	5.33e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—kidney cancer	3.12e-06	5.31e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTP1—kidney cancer	3.08e-06	5.24e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—BCHE—kidney cancer	2.98e-06	5.08e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SLC5A5—kidney cancer	2.95e-06	5.02e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—ABCB1—kidney cancer	2.91e-06	4.96e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—POMC—kidney cancer	2.87e-06	4.89e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—SLC2A1—kidney cancer	2.85e-06	4.85e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—GSTM1—kidney cancer	2.83e-06	4.81e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.83e-06	4.81e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—CYP1A1—kidney cancer	2.68e-06	4.56e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.58e-06	4.39e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—POMC—kidney cancer	2.57e-06	4.37e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—POMC—kidney cancer	2.5e-06	4.26e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTGS2—kidney cancer	2.5e-06	4.25e-05	CbGpPWpGaD
Omeprazole—CYP1B1—Metabolism—PIK3CA—kidney cancer	2.5e-06	4.25e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTP1—kidney cancer	2.37e-06	4.04e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—POMC—kidney cancer	2.36e-06	4.02e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—POMC—kidney cancer	2.34e-06	3.98e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTGS2—kidney cancer	2.29e-06	3.9e-05	CbGpPWpGaD
Omeprazole—ABCG2—Metabolism—PIK3CA—kidney cancer	2.27e-06	3.87e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—ABCB1—kidney cancer	2.25e-06	3.83e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CA—kidney cancer	2.2e-06	3.75e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—GSTM1—kidney cancer	2.18e-06	3.71e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PTEN—kidney cancer	2.18e-06	3.71e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—CYP1A1—kidney cancer	2.07e-06	3.52e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTGS2—kidney cancer	2.05e-06	3.48e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PTEN—kidney cancer	2e-06	3.4e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—POMC—kidney cancer	2e-06	3.4e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTGS2—kidney cancer	2e-06	3.4e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTGS2—kidney cancer	1.88e-06	3.2e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTGS2—kidney cancer	1.87e-06	3.17e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PTEN—kidney cancer	1.78e-06	3.04e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PTEN—kidney cancer	1.74e-06	2.96e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PTEN—kidney cancer	1.64e-06	2.79e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PTEN—kidney cancer	1.63e-06	2.77e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTGS2—kidney cancer	1.59e-06	2.71e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—POMC—kidney cancer	1.54e-06	2.63e-05	CbGpPWpGaD
Omeprazole—CYP1A1—Metabolism—PIK3CA—kidney cancer	1.54e-06	2.62e-05	CbGpPWpGaD
Omeprazole—CYP2C8—Metabolism—PIK3CA—kidney cancer	1.41e-06	2.4e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PTEN—kidney cancer	1.39e-06	2.37e-05	CbGpPWpGaD
Omeprazole—CYP2C19—Metabolism—PIK3CA—kidney cancer	1.26e-06	2.14e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTGS2—kidney cancer	1.23e-06	2.09e-05	CbGpPWpGaD
Omeprazole—ABCB1—Metabolism—PIK3CA—kidney cancer	1.23e-06	2.09e-05	CbGpPWpGaD
Omeprazole—CYP2D6—Metabolism—PIK3CA—kidney cancer	1.16e-06	1.97e-05	CbGpPWpGaD
Omeprazole—CYP2C9—Metabolism—PIK3CA—kidney cancer	1.15e-06	1.95e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PTEN—kidney cancer	1.07e-06	1.83e-05	CbGpPWpGaD
Omeprazole—CYP1A2—Metabolism—PIK3CA—kidney cancer	9.81e-07	1.67e-05	CbGpPWpGaD
Omeprazole—CYP3A4—Metabolism—PIK3CA—kidney cancer	7.57e-07	1.29e-05	CbGpPWpGaD
